carterra lsa overview | ht-spr | biotechnology | high-res epitope binning | antibody screening
Published 3 years ago • 4K plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
30:14
high res epitope binning | antibody screening | high-throughput antibody screening | lsa platform
-
59:04
accelerating drug discovery at a pandemic pace | high-res epitope binning | ht-spr | lsa platform
-
45:02
speed up your antibody discovery | high-res epitope binning | biology solutions | lsa platform
-
22:43
ht-spr technology | high-throughput antibody screening | biology solutions | lsa platform
-
1:00:03
carterra | sino biological | lsa | lsa-xt | ht-spr | high-resolution kinetics and epitope binning
-
49:27
therapeutic antibody screening in post genomics era | ht-spr | carterra lsa platform | biotech
-
54:00
high quality therapeutic antibodies | high-throughput antibody screening | ht-spr | lsa platform
-
56:57
high throughput antibody screening using synthetic libraries coupled with kinetic & binning assays
-
33:16
carterra cso speaks at sept 2018 seminar | monoclonal antibody (mab) | ht-spr | lsa platform
-
6:12
carterra live @ pegs europe 2021 | high-throughput antibody screening | lsa platform | biotechnology
-
44:13
screen biotherapeutic targets using carterra's software suite | high-throughput antibody screening
-
59:12
accelerating discovery of therapeutic antibodies using ht-spr | biology solutions | lsa platform
-
18:33
improve therapeutic antibody screening | leverage ht-spr to complement alphalisa | lsa platform
-
56:50
accelerate antibody discovery with ht kinetic screening of phage libraries | carterra lsa platform
-
43:46
fastest kinetic screening for antibody discovery | biotechnology | biology solutions | lsa platform
-
1:22:45
therapeutic antibodies in post genomics era | high-throughput antibody screening | lsa platform
-
23:53
aet europe 2023: the new carterra lsa-xt and ht-spr characterization of multi-specific antibodies
-
49:10
accelerated high-throughput and high-content antibody discovery targeting sars-cov-2 spike protein